Our previous studies on mammary tumors in age-matched PyMTWT and PyMTSB2-/- mice demonstrated that SerpinB2 loss delayed tumor onset and significantly reduced tumor incidence rate and volume in the 4th-5th glands in PyMTSB2−/− mice compared to PyMTWT mice [16]. Here, SERPINB2 is linked to breast cancer.